Vanguard's reduction below 5% removes a passive floor holder and may signal continued selling. Monitor for further 13G amendments or a full exit. The stock's normal daily move of 2.8% suggests this event alone could drive a modest negative reaction, but the gradual nature of index fund rebalancing limits urgency.
Price Chart
Executive Summary
Vanguard Portfolio Management LLC filed an amended Schedule 13G disclosing a 4.74% passive stake in Astrana Health, Inc., down from the prior 5%+ level. The stake decreased to 2,642,655 shares as of September 30, 2026, falling below the 5% reporting threshold. This reduction signals a gradual exit by a major index-oriented holder, which is a mildly bearish signal for the stock.
Key Financial Metrics
Key Facts
- Vanguard Portfolio Management LLC reported beneficial ownership of 2,642,655 shares of Astrana Health common stock as of September 30, 2026.
- The stake represents 4.74% of shares outstanding, down from above 5% in prior filings.
- The filing is an amendment to Schedule 13G, indicating passive investment intent.
- The filer is a subsidiary of The Vanguard Group, a large index fund manager.
- The filing date is October 30, 2026, with a date of change of September 30, 2026.
Financial Impact
Vanguard reduced its stake from above 5% to 4.74%, representing a decrease of at least 0.26% of shares outstanding. At a $1.8B market cap, this implies a reduction of roughly $4.7M+ in holdings.
Risk Factors
- Continued index fund selling pressure if Vanguard further reduces its position.
- Loss of a large, stable institutional holder could reduce liquidity and increase volatility.
- No activist or strategic intent disclosed; passive filing limits upside catalyst potential.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G/A Filing (Primary) | 0002100121-26-001050 |
| Document: 0002100121-26-001050-index.html | 0002100121-26-001050 |
| Document: 0002100121-26-001050.txt | 0002100121-26-001050 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 30, 2026 2d ago | SC 13G/A | $35.98 | awaiting T+20 | awaiting T+20 | $36.53 (−1.53%) |
Sep 23, 2026 5w ago | 8-K | $34.34 $37.35 | ▲ +8.77% | ▲ +8.08% | $36.53 (+6.38%) |
Sep 23, 2026 5w ago | 8-K | $34.34 $37.35 | ▼ −8.77% | ▼ −8.08% | $36.53 (−6.38%) |
Sep 15, 2026 6w ago | 8-K | $38.35 $37.87 | ▼ −1.25% | ▼ −4.23% | $36.53 (−4.75%) |
Jul 14, 2026 15w ago | Press Release | $47.04 $35.79 | ▼ −23.92% | ▼ −26.26% | $36.53 (−22.34%) |
Jul 13, 2026 15w ago | 8-K | $47.64 $37.47 | ▼ −21.35% | ▼ −24.53% | $36.53 (−23.32%) |
Jun 10, 2026 20w ago | 8-K | $39.85 $46.81 | ▲ +17.47% | ▲ +15.57% | $36.53 (−8.33%) |
Apr 17, 2026 28w ago | DEFA14A | $31.50 $39.16 | ▲ +24.32% | ▲ +18.95% | $36.53 (+15.97%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers